BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31782447)

  • 1. Selective targeting of the DEAD-box RNA helicase eukaryotic initiation factor (eIF) 4A by natural products.
    Shen L; Pelletier J
    Nat Prod Rep; 2020 May; 37(5):609-616. PubMed ID: 31782447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA-mediated sequestration of the RNA helicase eIF4A by Pateamine A inhibits translation initiation.
    Bordeleau ME; Cencic R; Lindqvist L; Oberer M; Northcote P; Wagner G; Pelletier J
    Chem Biol; 2006 Dec; 13(12):1287-95. PubMed ID: 17185224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of small molecules targeting eIF4A.
    Naineni SK; Itoua Maïga R; Cencic R; Putnam AA; Amador LA; Rodriguez AD; Jankowsky E; Pelletier J
    RNA; 2020 May; 26(5):541-549. PubMed ID: 32014999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational dysregulation by Pateamine A.
    Korneeva NL
    Chem Biol; 2007 Jan; 14(1):5-7. PubMed ID: 17254945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the mechanism of action of a potent pateamine A analog, des-methyl, des-amino pateamine A (DMDAPatA).
    Kommaraju SS; Aulicino J; Gobbooru S; Li J; Zhu M; Romo D; Low WK
    Biochem Cell Biol; 2020 Aug; 98(4):502-510. PubMed ID: 32008367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate-dependent targeting of eukaryotic translation initiation factor 4A by pateamine A: negation of domain-linker regulation of activity.
    Low WK; Dang Y; Bhat S; Romo D; Liu JO
    Chem Biol; 2007 Jun; 14(6):715-27. PubMed ID: 17584618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stopping trouble before it starts.
    Clardy J
    ACS Chem Biol; 2006 Feb; 1(1):17-9. PubMed ID: 17163634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of translation initiation as cancer therapeutics.
    Lindqvist L; Pelletier J
    Future Med Chem; 2009 Dec; 1(9):1709-22. PubMed ID: 21425987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of eukaryotic translation initiation by the marine natural product pateamine A.
    Low WK; Dang Y; Schneider-Poetsch T; Shi Z; Choi NS; Merrick WC; Romo D; Liu JO
    Mol Cell; 2005 Dec; 20(5):709-22. PubMed ID: 16337595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of mammalian translation initiation factor eIF4A activity by a small molecule inhibitor of eukaryotic translation.
    Bordeleau ME; Matthews J; Wojnar JM; Lindqvist L; Novac O; Jankowsky E; Sonenberg N; Northcote P; Teesdale-Spittle P; Pelletier J
    Proc Natl Acad Sci U S A; 2005 Jul; 102(30):10460-5. PubMed ID: 16030146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of translation targeting eukaryotic translation initiation factor 4A.
    Cencic R; Galicia-Vázquez G; Pelletier J
    Methods Enzymol; 2012; 511():437-61. PubMed ID: 22713332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective pharmacological targeting of a DEAD box RNA helicase.
    Lindqvist L; Oberer M; Reibarkh M; Cencic R; Bordeleau ME; Vogt E; Marintchev A; Tanaka J; Fagotto F; Altmann M; Wagner G; Pelletier J
    PLoS One; 2008 Feb; 3(2):e1583. PubMed ID: 18270573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting RNA helicases in cancer: The translation trap.
    Heerma van Voss MR; van Diest PJ; Raman V
    Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):510-520. PubMed ID: 28965870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amidino-Rocaglates: A Potent Class of eIF4A Inhibitors.
    Chu J; Zhang W; Cencic R; Devine WG; Beglov D; Henkel T; Brown LE; Vajda S; Porco JA; Pelletier J
    Cell Chem Biol; 2019 Nov; 26(11):1586-1593.e3. PubMed ID: 31519508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor.
    Iwasaki S; Floor SN; Ingolia NT
    Nature; 2016 Jun; 534(7608):558-61. PubMed ID: 27309803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational dysregulation in cancer: eIF4A isoforms and sequence determinants of eIF4A dependence.
    Raza F; Waldron JA; Quesne JL
    Biochem Soc Trans; 2015 Dec; 43(6):1227-33. PubMed ID: 26614665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP-competitive, marine derived natural products that target the DEAD box helicase, eIF4A.
    Tillotson J; Kedzior M; Guimarães L; Ross AB; Peters TL; Ambrose AJ; Schmidlin CJ; Zhang DD; Costa-Lotufo LV; Rodríguez AD; Schatz JH; Chapman E
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4082-4085. PubMed ID: 28757063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and identification of eukaryotic initiation factor 4A as a molecular target for the marine natural product Pateamine A.
    Low WK; Dang Y; Schneider-Poetsch T; Shi Z; Choi NS; Rzasa RM; Shea HA; Li S; Park K; Ma G; Romo D; Liu JO
    Methods Enzymol; 2007; 431():303-24. PubMed ID: 17923240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptome-wide characterization of the eIF4A signature highlights plasticity in translation regulation.
    Rubio CA; Weisburd B; Holderfield M; Arias C; Fang E; DeRisi JL; Fanidi A
    Genome Biol; 2014; 15(10):476. PubMed ID: 25273840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A helicase-independent activity of eIF4A in promoting mRNA recruitment to the human ribosome.
    Sokabe M; Fraser CS
    Proc Natl Acad Sci U S A; 2017 Jun; 114(24):6304-6309. PubMed ID: 28559306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.